CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity | MicrobiomeTrials
CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-11-16Est. Completion: 2027-02-28
Enrollment target: 113 participants
Locations
CH Bagnères, Bagnères-de-Bigorre, France
CH Bar le Duc, Bar-le-Duc, France
Besançon - CHU/CRRF de Bréguille/Salin les bains, Besançon, France
CHU Bordeaux - Hopital Tastet-Girard, Bordeaux, France
CH Bourg en Bresse, Bourg-en-Bresse, France
CHU Brest, Brest, France
Centre de rééducation des 3 vallées, Corbie, France
CH Dax, Dax, France
Fondation hopale - Fouqière-lez-Lens, Fouquières-lès-Lens, France
Clinique de Verdaich, Gaillac-Toulza, France
HCL - Renée Sabran, Hyères, France
Crf Bel Air, La Membrolle-sur-Choisille, France
CHU Lille, Lille, France
CHU Nice, Nice, France
CHU Nîmes, Nîmes, France
Hôpital Rothschild, Paris, France
Ste Anne, Paris, France
Hôpital Fondation Adolphe de Rothschild, Paris, France
CHU Reims, Reims, France
CHU Rennes, Rennes, France
Pole St Hélier, Rennes, France
Other microbiome trials you might be interested in